On Biology
Benefits and risks preferences for new medicines in rare diseases
Orphanet Journal of Rare Diseases has recently published an article quantifying the benefit-risk preferences for new medicines in rare disease patients and caregivers. Editor-in-Chief for the journal Ségolène Aymé discusses this publication fur
No hay comentarios:
Publicar un comentario